Abstract
The protein kinase C (PKC) Ser/Thr kinases account for ∼2% of the human kinome and regulate diverse cellular behaviors. PKC catalytic activity requires priming phosphorylations at three conserved sites within the kinase domain. Here we demonstrate that priming of PKC is dependent on the conformation of the nucleotide binding pocket but not on its intrinsic kinase activity. Inactive ATP binding site mutants are unprimed, but they become phosphorylated upon occupancy of the ATP binding pocket with inhibitors of PKC. We have exploited this property to screen for PKC inhibitors in vivo. Further, we generated a distinct class of kinase-inactive mutants that maintain the integrity of the ATP binding pocket; such mutants are constitutively primed and functionally distinct from ATP binding site mutants. These data demonstrate that autophosphorylation is not required for PKC priming and show how ATP pocket occupation can enable a kinase to mature as well as function.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Parekh, D.B., Ziegler, W. & Parker, P.J. Multiple pathways control protein kinase C phosphorylation. EMBO J. 19, 496–503 (2000).
Frödin, M. et al. A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. EMBO J. 21, 5396–5407 (2002).
Hauge, C. et al. Mechanism for activation of the growth factor-activated AGC kinases by turn motif phosphorylation. EMBO J. 26, 2251–2261 (2007).
Nishizuka, Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308, 693–698 (1984).
Mellor, H. & Parker, P.J. The extended protein kinase C superfamily. Biochem. J. 332, 281–292 (1998).
Gibbs, C.S. & Zoller, M.J. Rational scanning mutagenesis of a protein kinase identifies functional regions involved in catalysis and substrate interactions. J. Biol. Chem. 266, 8923–8931 (1991).
Ohno, S., Konno, Y., Akita, Y., Yano, A. & Suzuki, K. A point mutation at the putative ATP-binding site of protein kinase C α abolishes the kinase activity and renders it down-regulation-insensitive. A molecular link between autophosphorylation and down-regulation. J. Biol. Chem. 265, 6296–6300 (1990).
Takahashi, M., Mukai, H., Oishi, K., Isagawa, T. & Ono, Y. Association of immature hypophosphorylated protein kinase Cε with an anchoring protein CG-NAP. J. Biol. Chem. 275, 34592–34596 (2000).
Behn-Krappa, A. & Newton, A.C. The hydrophobic phosphorylation motif of conventional protein kinase C is regulated by autophosphorylation. Curr. Biol. 9, 728–737 (1999).
Cenni, V. et al. Regulation of novel protein kinase C ε by phosphorylation. Biochem. J. 363, 537–545 (2002).
Alessi, D.R. et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541–6551 (1996).
Martiny-Baron, G. et al. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J. Biol. Chem. 268, 9194–9197 (1993).
Hidaka, H., Inagaki, M., Kawamoto, S. & Sasaki, Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23, 5036–5041 (1984).
Davies, S.P., Reddy, H., Caivano, M. & Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95–105 (2000).
Bornancin, F. & Parker, P.J. Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase Cα. Curr. Biol. 6, 1114–1123 (1996).
Bornancin, F. & Parker, P.J. Phosphorylation of protein kinase C-α on serine 657 controls the accumulation of active enzyme and contributes to its phosphatase-resistant state. J. Biol. Chem. 272, 3544–3549 (1997).
Bishop, A.C., Buzko, O. & Shokat, K.M. Magic bullets for protein kinases. Trends Cell Biol. 11, 167–172 (2001).
Durgan, J. et al. The identification and characterization of novel PKCε phosphorylation sites provide evidence for functional cross-talk within the PKC superfamily. Biochem. J. 411, 319–331 (2008).
Qi, Z.H. et al. Protein kinase C ε regulates γ-aminobutyrate type A receptor sensitivity to ethanol and benzodiazepines through phosphorylation of γ2 subunits. J. Biol. Chem. 282, 33052–33063 (2007).
Boudeau, J., Miranda-Saavedra, D., Barton, G.J. & Alessi, D.R. Emerging roles of pseudokinases. Trends Cell Biol. 16, 443–452 (2006).
Cameron, A.J., Procyk, K.J., Leitges, M. & Parker, P.J. PKC α protein but not kinase activity is critical for glioma cell proliferation and survival. Int. J. Cancer 123, 769–779 (2008).
Whelan, R.D. & Parker, P.J. Loss of protein kinase C function induces an apoptotic response. Oncogene 16, 1939–1944 (1998).
Gassel, M. et al. The protein kinase C inhibitor bisindolyl maleimide 2 binds with reversed orientations to different conformations of protein kinase A. J. Biol. Chem. 279, 23679–23690 (2004).
Huang, X. et al. Crystal structure of an inactive Akt2 kinase domain. Structure 11, 21–30 (2003).
Zhao, B. et al. Crystal structure of the kinase domain of serum and glucocorticoid-regulated kinase 1 in complex with AMP PNP. Protein Sci. 16, 2761–2769 (2007).
Smith, K.J. et al. The structure of MSK1 reveals a novel autoinhibitory conformation for a dual kinase protein. Structure 12, 1067–1077 (2004).
Grodsky, N. et al. Structure of the catalytic domain of human protein kinase C β II complexed with a bisindolylmaleimide inhibitor. Biochemistry 45, 13970–13981 (2006).
Messerschmidt, A. et al. Crystal structure of the catalytic domain of human atypical protein kinase C-iota reveals interaction mode of phosphorylation site in turn motif. J. Mol. Biol. 352, 918–931 (2005).
Xu, Z.B. et al. Catalytic domain crystal structure of protein kinase C-θ (PKCθ). J. Biol. Chem. 279, 50401–50409 (2004).
Ikenoue, T., Inoki, K., Yang, Q., Zhou, X. & Guan, K.L. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J. 27, 1919–1931 (2008).
Facchinetti, V. et al. The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J. 27, 1932–1943 (2008).
Le Good, J.A. et al. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281, 2042–2045 (1998).
Srivastava, J., Goris, J., Dilworth, S.M. & Parker, P.J. Dephosphorylation of PKCδ by protein phosphatase 2Ac and its inhibition by nucleotides. FEBS Lett. 516, 265–269 (2002).
Papa, F.R., Zhang, C., Shokat, K. & Walter, P. Bypassing a kinase activity with an ATP-competitive drug. Science 302, 1533–1537 (2003).
Parekh, D., Ziegler, W., Yonezawa, K., Hara, K. & Parker, P.J. Mammalian TOR controls one of two kinase pathways acting upon nPKCδ and nPKCε. J. Biol. Chem. 274, 34758–34764 (1999).
Hansra, G. et al. Multisite dephosphorylation and desensitization of conventional protein kinase C isotypes. Biochem. J. 342, 337–344 (1999).
Saurin, A.T. et al. The regulated assembly of a PKCε complex controls the completion of cytokinesis. Nat. Cell Biol. 10, 891–901 (2008).
Gopalakrishna, R., Chen, Z.H. & Gundimeda, U. Irreversible oxidative inactivation of protein kinase C by photosensitive inhibitor calphostin C. FEBS Lett. 314, 149–154 (1992).
Acknowledgements
We thank R. Messing for the characterization of PKCε M486A chemical genetic mutants, M. Howell for assistance with the Calbiochem Inhibitor library screen, A. Hibbert for statistical advice and R. Mitter for help with data presentation. We also acknowledge N. MacDonald, M. De Rycker, W. Hanage and A. Jevons for critical reading of the manuscript. C.E. gratefully acknowledges the support of Jose Luis Rodríguez-Fernández (Madrid).
Author information
Authors and Affiliations
Contributions
A.J.M.C. carried out all the experiments in this study; A.J.M.C. jointly conceived the project (with P.J.P.) and wrote the manuscript with help from P.J.P.; C.E. helped with phosphomimetic mutants of PKC.; A.T.S. helped with PKCε constructs and tetracycline-inducible cell lines; B.K. contributed structural analysis of kinase domains.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1 and 2 and Supplementary Table 1 (PDF 388 kb)
Rights and permissions
About this article
Cite this article
Cameron, A., Escribano, C., Saurin, A. et al. PKC maturation is promoted by nucleotide pocket occupation independently of intrinsic kinase activity. Nat Struct Mol Biol 16, 624–630 (2009). https://doi.org/10.1038/nsmb.1606
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb.1606
This article is cited by
-
Equivocal, explicit and emergent actions of PKC isoforms in cancer
Nature Reviews Cancer (2021)
-
Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors
Nature Communications (2020)
-
A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle
Nature Communications (2018)
-
New perspectives for targeting RAF kinase in human cancer
Nature Reviews Cancer (2017)
-
Computational insights into HER3 gatekeeper T768I resistance mutation to bosutinib in HER3-related breast cancer
Medicinal Chemistry Research (2017)